FOR IMMEDIATE RELEASE
OCTOBER 22,1993
LEAHY WILL FIGHT FOR $25 MILLION
BREAST CANCER RESEARCH; VOWS TO TAKE BATTLE TO THE HOUSE
WASHINGTON, D.C.--The
Senate last night approved Senator Patrick Leahy's effort to pump $25 million
into breast cancer research. But Leahy says the fight is just beginning.
Leahy says the battle now
shifts to a Senate/House conference to assure the funds stay in place and
are not siphoned off to finance other Defense Department projects.
The Vermont senator will
be a conferee on the bill that he amended to include breast cancer research
funding, despite some Pentagon opposition. Secretary Aspin failed to set
aside any Department of Defense research funds in the budget despite Congressional
approval of $2 1 0 million last year.
Leahy successfully fought
language that he labeled "blatantly sexist" in last year's bill, after
the department set aside research funds for prostate cancer but balked-
on including breast cancer research in the DoD budget.
Leahy joined women protestors
on the steps of the Capitol last year to dramatize the need for more research
into the causes of breast cancer, which has a higher mortality incidence
in Vermont than most other states.
"With the funds approved
last year, this program has recruited new scientists into a critical field
of research and brought thousands of innovative proposals forward," Leahy
said.
Leahy said the $25 million
in research funds signals researchers that the "Congress won't give up
until we find out what is killing our mothers, wives and daughters."
"We have to keep going."
Leahy's efforts have won
the praise of Fran Visco, President of the National Breast Cancer Coalition.
"Once again, Senator Leahy's
leadership has been pivotal in our fight to obtain the research funds necessary
to eradicate breast cancer," Visco said.
"His action ensures that
the important research effort begun last year at the Department of Army
will continue."
Leahy joined with Senator
Tom Harkin (D-IA) last year in an effort to save $210 million intended
for breast cancer research as part of the Defense Appropriations bill.
The two Senators protested what Leahy called "an act of cruel, mean sexism,"
when they learned that breast cancer funding had been cut while funding
for prostate cancer remained in the bill. The funding was eventually approved.
The defense spending measure
now goes to a conference committee of House and Senate members.

|